Companies: 10,651     total market cap: $139.941 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
โ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
iShares Biotechnology ETF
IBB
#296
ETF rank
$8.50 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
$172.43
Share price
-1.04%
Change (1 day)
24.53%
Change (1 year)
๐Ÿงฌ Biotech ETFs
Categories
iShares Biotechnology ETF (IBB) seeks to track the performance of the NYSE Biotechnology Index, providing exposure to U.S.-listed companies in the biotechnology sector. The fund offers targeted access to biotech stocks, allowing investors to express a view on the industry.

Market capitalization of iShares Biotechnology ETF (IBB)

Market cap: $8.50 Billion USD

As of February 2026 iShares Biotechnology ETF has a market cap of $8.50 Billion USD. The market capitalization, commonly called market cap of this exchange traded fund calculated by multiplying the outstanding shares with the current share price.

Market cap history of iShares Biotechnology ETF in 2026

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com